Vascular News and Research

RSS

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.

8 Sep 2014

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration, South Korea’s Ministry of Food and Drug Safety, and the Taiwan Food and Drug Administration for the company’s REVIVE SE Thrombectomy Device, a next-generation self-expanding clot removal device intended to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

4 Sep 2014

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world.

4 Sep 2014

New way to reduce abnormal blood vessel growth and leakage in eye

Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to the development of new drugs for wet macular degeneration and diabetic macular edema.

4 Sep 2014

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.

3 Sep 2014

Using molecular imaging probes diabetic retinopathy can be detected at molecular level

A new study published in the September issue of The FASEB Journal, identifies a novel strategy to diagnose the leading cause of blindness in adults, diabetic retinopathy, before irreversible structural damage has occurred.

3 Sep 2014

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.

2 Sep 2014

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted.

From COOK MEDICAL INC. 2 Sep 2014

Surgical researchers rarely use female animals in medical research

A new study from Northwestern Medicine- has found that surgical researchers rarely use female animals or female cells in their published studies -- despite a huge body of evidence showing that sex differences can play a crucial role in medical research.

30 Aug 2014

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France).

30 Aug 2014

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

The ACCA Clinical Decision-Making Toolkit mobile app is now available on the App Store and Google Play. When dealing with acute cardiovascular diseases, a few seconds can make the difference and instant access to the best recommendations can save lives.

30 Aug 2014

New research identifies five medical conditions that contribute to more North Carolina SUD cases

Sudden unexpected death (SUD) results from a malfunction of the heart and causes a rapid loss of blood flow through the body, leading to death. It is a very rapid process and may have few or no known warning signs. The overall survival rate for out-of-hospital arrest is only 5-10%. SUD is responsible for upwards of 450,000 people in the United States each year, with North Carolina experiencing an average of 32 SUD-related deaths each day.

29 Aug 2014

Reticular pseudodrusen predicts late-stage AMD

Reticular pseudodrusen increases the likelihood of people with choroidal neovascularisation in one eye also developing late-stage, age-related macular degeneration in the other eye, researchers report.

28 Aug 2014

Macular ischaemia, retinal thinning linked to reduced visual function in diabetic retinopathy

Macular ischemia and retinal thinning are associated with reduced visual function in patients with diabetic retinopathy, research suggests.

28 Aug 2014

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide.

28 Aug 2014

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Oxidized lipids are known to play a key role in inflaming blood vessels and hardening arteries, which causes diseases like atherosclerosis. A new study at UCLA demonstrates that they may also contribute to pulmonary hypertension, a serious lung disease that narrows the small blood vessels in the lungs.

28 Aug 2014

Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Cognitive impairment is the loss of brain functions like short and long term memory, the ability to plan ahead or conduct more complicated intellectual tasks.

27 Aug 2014

Study examines ocular changes seen in astronauts to treat spaceflight-induced visual impairment

To reduce and better treat spaceflight-induced visual impairment, University of Houston (UH) optometrists are collaborating on a NASA study that examines ocular changes seen in a number of astronauts.

27 Aug 2014

People with cognitive impairment are more likely to have stroke

People with cognitive impairment are significantly more likely to have a stroke, with a 39% increased risk, than people with normal cognitive function, according to a new study published in CMAJ (Canadian Medical Association Journal).

26 Aug 2014

Exercising to improve cardiovascular strength may protect from cognitive impairment

Exercising to improve our cardiovascular strength may protect us from cognitive impairment as we age, according to a new study by researchers at the University of Montreal and its affiliated Institut universitaire de gératrie de Montréal Research Centre.

25 Aug 2014

Vascular News and Research

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

New way to reduce abnormal blood vessel growth and leakage in eye

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Using molecular imaging probes diabetic retinopathy can be detected at molecular level

Digoxin drug increases risk of adverse cardiovascular events or sudden death

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Surgical researchers rarely use female animals in medical research

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

New research identifies five medical conditions that contribute to more North Carolina SUD cases

Reticular pseudodrusen predicts late-stage AMD

Macular ischaemia, retinal thinning linked to reduced visual function in diabetic retinopathy

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

New UCLA study finds that oxidized lipids may also contribute to pulmonary hypertension

Cognitive impairment communication: an interview with Marc Wortmann, Executive Director, Alzheimer’s Disease International (ADI)

Study examines ocular changes seen in astronauts to treat spaceflight-induced visual impairment

People with cognitive impairment are more likely to have stroke

Exercising to improve cardiovascular strength may protect from cognitive impairment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News